Migdal Insurance & Financial Holdings Ltd. Werewolf Therapeutics, Inc. Transaction History

Migdal Insurance & Financial Holdings Ltd.

$6.18 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 10, 2022	SELL	$3.43 - $5.98 $643,125 - $1.12 Million	-187,500 Closed	0 $0
Q2 2021 Aug 04, 2021	BUY	$11.6 - $17.44 $2.18 Million - $3.27 Million	187,500 New	187,500 $3.27 Million

Others Institutions Holding HOWL

# of Institutions

Shares Held

31.8M

Call Options Held

700

Put Options Held

500

Ra Capital Management, L.P. Boston, MA

6.14M
Shares

$8.85 Million
0.18% of portfolio
Mpm Asset Management LLC Cambridge, MA

4.28M
Shares

$6.17 Million
6.25% of portfolio
Pfm Health Sciences, LP San Francisco, CA

3.4M
Shares

$4.89 Million
0.42% of portfolio
Bio Impact Capital LLC Cambridge, MA

2.39M
Shares

$3.44 Million
0.79% of portfolio
Bank Of America Corp Charlotte, NC

2.15M
Shares

$3.1 Million
0.0% of portfolio

View Full List

About Werewolf Therapeutics, Inc.

Ticker HOWL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,529,400
Market Cap $42.5M
Description
Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...

More about HOWL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Migdal Insurance & Financial Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Migdal Insurance & Financial Holdings Ltd. with notifications on news.

Account